metastatic urothelial cancer research hub
3 indexed studies · 1 currently recruiting
- ongoing, recruitingTherapeutic exploratory (Phase II)
PembrolizuMab beyond RECIST progression and oral metroNOmic cyclophosphamide in meTAstatic UROthelial cancer: a single-arm, monocentre, phase 2 trial: minotaURO study
This study is looking at a new way to treat bladder cancer that has spread. It combines immunotherapy (pembrolizumab) with a cancer drug (cyclophosphamide) to see if it can stop the cancer from getting worse for longer. It's for adults and focuses on how well the treatment works.
Italy - recruitingPHASE2
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
This study looks at new ways to treat bladder cancer that has spread or can't be removed with surgery. It's testing a drug called sacituzumab govitecan, sometimes on its own, and sometimes with other new treatments, to see if they are safe and effective.
United States · France · Germany - active not recruitingPHASE2
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
This study is testing new treatments for advanced bladder cancer. It compares a new drug, zelenectide pevedotin, alone and with pembrolizumab, against standard chemotherapy. We want to see how well these treatments work and if they are safe for people with bladder cancer that has spread.
United States · Argentina · Australia